Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
ACS Medicinal Chemistry Letters|May 20, 2017
Discovery of Orally Efficacious Tetrahydrobenzimidazoles as TGR5 Agonists for Type 2 DiabetesXuqing Zhang, Mark Wall, Zhihua Sui, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2007
beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituentsShyh-Ming Yang, Robert H Scannevin, Bingbing Wang, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Synthesis and evaluation of nonpeptide substituted spirobenzazepines as potent vasopressin antagonistsMin Amy Xiang, Robert H Chen, Keith T Demarest, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2009
Discovery and SAR of para-alkylthiophenoxyacetic acids as potent and selective PPARdelta agonistsRui Zhang, Alan Deangelis, Aihua Wang, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2004
Novel non-peptidic neuropeptide Y Y2 receptor antagonistsJill A Jablonowski, Wenying Chai, Xiaobing Li, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2018
Synthesis and biological evaluation of benzocyclobutane-C-glycosides as potent and orally active SGLT1/SGLT2 dual inhibitorsGee-Hong Kuo, Micheal D Gaul, Yin Liang, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Discovery of an Isothiazole-Based Phenylpropanoic Acid GPR120 Agonist as a Development Candidate for Type 2 DiabetesXuqing Zhang, Chaozhong Cai, Zhihua Sui, et al.
Pageof 5